14 January 2016 in Oncology Letters
Intercellular adhesion molecule 1 (ICAM‑1) is important in the progression of inflammatory responses. Recently, increased levels of ICAM‑1 have been reported in a number of types of malignancy. The present study aimed to investigate ICAM‑1 expression in papillary thyroid cancer (PTC) and in Hashimoto's thyroiditis (HT) with PTC‑like nuclear alterations, and to assess the predictive value of ICAM‑1 in thyroid lesions. ICAM‑1 expression was retrospectively investigated in 132 consecutive cases of PTC, 72 cases of HT, 10 of follicular cancer, 15 of follicular adenoma, 16 of nodular goiter and 8 samples of normal thyroid tissue using immunohistochemical analyses, and in 42 PTC patients using western blotting. ICAM‑1 expression was not detected in normal follicular cells, follicular lesions (adenoma and cancer) and benign nodular hyperplasia, but was frequently overexpressed in PTC cells. ICAM‑1 overexpression was associated with extra‑thyroidal invasion and lymph node metastasis; no association was found with age, gender, tumor size, multifocality, pathological stage, recurrence or distant metastasis. ICAM‑1 expression in HT patients with PTC‑like nuclear alterations was significantly higher than that in HT cases with non‑PTC‑like features. Compared with antibodies against cytokeratin 19, galectin‑3 and Hector Battifora mesothelial‑1, ICAM‑1 was the most sensitive marker for the detection of PTC‑like features in HT. These findings demonstrate that ICAM‑1 expression is upregulated in PTC and in HT with PTC‑like nuclear alterations. This feature may be an important factor in the progression of cancer of the thyroid gland.
20 July 2017 in Oncology Letters
Esophageal cancer‑related gene 4 (ECRG4) is a candidate tumor suppressor gene, which is involved in cell apoptosis, migration, infection and inflammation responsiveness; however, its expression level and clinical significance in hepatocellular carcinoma (HCC) remains unclear. In the present study, the authors aim to evaluate the clinical significance and potential role of ECRG4 in HCC. Level of ECRG4 protein expression in HCC and peripheral tissues was investigated in tissue specimens obtained from 56 consecutive HCC patients by immunohistochemistry. Cell proliferation, cell migration and invasion regulations were examined by MTT curves, flow cytometry, Transwell assays and western blotting. ECRG4 expression was weak positive in normal liver cells but was downregulated in HCC cells in vivo or in vitro. A decreased expression of ECRG4 was associated with the age of the patients, metastasis and Ki‑67 proliferation index. However, decreased ECRG4 expression was not associated with differentiation, tumor size, the presence of portal vein tumor thrombosis, satellite lesions, tumor relapse or mortality. Further investigations revealed that ectopic expression of ECRG4 inhibited cell proliferation, migration and invasion and promoted cell apoptosis in SMMC‑7721 cells, which was mediated by the regulation of BAX and B cell lymphoma‑2, in addition to the upregulation of epithelial‑mesenchymal transition markers. In conclusion, the results of the present study indicated that ECRG4 was downregulated in HCC and served important roles in promoting cell proliferation and migration.
20 December 2013 in Chinese Medical Journal
Background: Glucosylceramide synthase (GCS) can reduce ceramide levels and help cells escape ceramide-induced apoptosis, thus leading to multidrug resistance (MDR). However, its expression and clinical significance in thyroid neoplasms still remain unclear. We aimed to elucidate the expression of GCS and explore its correlation with the clinicopathological characteristics in papillary thyroid carcinomas (PTCs). Methods: We retrospectively investigated GCS protein expression level in tissue specimens obtained from 108 consecutive PTC patients by immunohistochemistry and Western blotting. Results: GCS was weakly positive or negative in normal follicular cells, but it was frequently overexpressed in PTC cells. GCS overexpression was associated with primary tumor size, local infiltration, lymph node metastasis, and local recurrence, but not associated with gender, age, pathological variants, tumor multifocality, tumor stage or distant metastasis. Western blotting also showed that GCS protein levels were much higher in PTCs' tissues than in normal thyroid tissues. Conclusion: GCS was upregulated in PTCs and might be an independent factor affecting prognosis.